Trial Profile
Global Left Ventricular Function After Acute Myocardial Infarction: Treatment With the Angiotensin 2-Receptor Blocker Irbesartan.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms GLOBAL
- 02 May 2018 Status changed from suspended to completed.
- 15 Aug 2011 Additional lead investigator (Kenneth Egstrup) added as reported by ClinicalTrials.gov.
- 15 Aug 2011 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.